ザルトリウス・ジャパン Official site

[Free Online Seminar] Key Points and Countermeasures for the Revision of EP 2.6.7

ザルトリウス・ジャパン

Recommended for the following individuals! ◼ Quality control (QC) personnel for biopharmaceuticals, cell therapy, and gene therapy products ◼ Those responsible for mycoplasma testing in a GMP environment ◼ Personnel in charge of microbiological testing, sterility testing, and rapid microbiological testing ◼ Those responsible for analytical method validation ◼ Heads and managers of quality assurance (QA) and quality control (QC) departments ◼ Those considering how to respond to the revision of EP 2.6.7 ◼ Those contemplating the introduction of rapid mycoplasma testing using NAT methods The revision of EP 2.6.7 has significantly revised the requirements regarding nucleic acid amplification tests (NAT) for mycoplasma. We will provide insights to deepen your understanding of the revision points and tips for utilizing the rapid mycoplasma testing Cyclus solution in response. We look forward to your participation! ◼ Event Overview Date and Time: November 19, 2026 (Thursday) 13:30–14:20 Format: Online (Teams) Application Deadline: November 16, 2026 (Monday) by 17:00 Participation Fee: Free